HDFC Trustee Company have picked 5.01% stake in Aurobindo Pharma for its different funds. The trustee company have purchased 145,93,640 equity shares amounting to 5.01% of the paid up equity share capital. The purchase was carried out in open market and the company did not provide the value of the acquisition.
The different funds of HDFC Trustee Company which bought stake in Aurobindo Pharma include, HDFC arbitrage fund, HDFC balanced fund, HDFC equity fund, HDFC prudence fund, HDFC top 200 fund and HDFC mid cap opportunities.
Aurobindo Pharma headquartered at Hyderabad, India, manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, WHO, Health Canada, MCC South Africa, ANVISA Brazil.
The Company has reported a net loss of Rs 101.58 crore for the quarter ended June 30, 2011 as compared to net profit of Rs 63.34 crore for the quarter ended June 30, 2010. The company’s total income registered growth of 18.77% at Rs 1031.87 crore for the June quarter of FY12 from Rs 868.81 crore for the June quarter of the previous Fiscal.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |